Accuray Incorporated announced that Sandeep Chalke has joined the company as senior vice president, chief commercial officer effective May 16, 2022. Mr. Chalke will have responsibility for the global commercial, product development, R&D and engineering functions for the company reporting to Accuray president and forthcoming CEO, Suzanne Winter. Mr. Chalke brings more than 25 years of medical device expertise in commercialization, business development and operations, spanning multiple healthcare industry segments including interventional catheterization systems, diagnostic x-ray, C-arm linear accelerators, anesthesia and respiratory care, advanced wound dressing & diabetes.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | -0.63% | +5.37% | -44.52% |
10/05 | Accuray Incorporated Announces Executive Changes, Effective May 17, 2024 | CI |
01/05 | Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q3 Revenue $101.1M, vs. Street Est of $113.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.52% | 156M | |
+6.02% | 215B | |
+9.25% | 187B | |
+19.58% | 143B | |
+29.74% | 110B | |
+1.63% | 64.68B | |
+15.27% | 52.96B | |
+2.69% | 49.84B | |
-5.47% | 38.32B | |
+1.58% | 35.86B |
- Stock Market
- Equities
- ARAY Stock
- News Accuray Incorporated
- Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer